Perrigo (PRGO) general counsel Atkinson acquired 6,690 shares at $10.83
Insider transactions reported
Charles Atkinson (EVP, General Counsel & Sec. at Perrigo Company plc, PRGO) reported that they acquired 6,690 shares at $10.83, and gave up 1,835 shares at $10.83 to cover taxes or an exercise price on Jun 5, 2026. After these transactions the filing shows 5,855 shares held directly.
- Reporting person
- Atkinson Charles
- Role
- EVP, General Counsel & Sec.
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Exercise or conversion of a derivative (M) | Ordinary Shares | +6,690 | $10.83 | $72.5K | 7,690 direct |
| Jun 5, 2026 | Shares withheld for taxes or exercise price (F) | Ordinary Shares | -1,835 | $10.83 | $19.9K | 5,855 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Exercise or conversion of a derivative (M) | Restricted Stock UnitsOn 6,690 Ordinary Shares1, 2 | -6,690 | - | - | 13,379 direct |
Holdings before and after
- Ordinary Shares: 1,000 to 5,855 direct
- Restricted Stock Units: 20,069 to 13,379 direct
Footnotes from the filing
- 1. Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
- 2. Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 6 June 2026.
Transaction codes in this filing
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Atkinson report in this PRGO Form 4?
Charles Atkinson (EVP, General Counsel & Sec. at Perrigo Company plc, PRGO) reported that they acquired 6,690 shares at $10.83, and gave up 1,835 shares at $10.83 to cover taxes or an exercise price on Jun 5, 2026. After these transactions the filing shows 5,855 shares held directly.
How many PRGO shares does Atkinson hold after this filing?
The filing shows 5,855 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code M mean on an SEC Form 4?
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
Historical context for PRGO
Across the 15 sessions after earlier PRGO headlines, the stock closed higher 5 times and lower 10 times, with a median move of 1.5% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | PRGO | SPY |
|---|---|---|---|
| May 26, 2026 | Perrigo to Present at the Oppenheimer 26th Annual Consumer Growth & E-Commerce Conference | -3.7% | +0.7% |
| May 7, 2026 | Perrigo Reports First Quarter 2026 Financial Results From Continuing Operations | -4.4% | -0.3% |
| May 1, 2026 | Perrigo Completes Divestiture of Dermacosmetics Business | +0.7% | +0.3% |
| Apr 29, 2026 | Perrigo Announces Quarterly Dividend | -1.9% | -0.0% |
| Apr 22, 2026 | Perrigo to Release First Quarter 2026 Financial Results on May 6, 2026 | +0.8% | +1.0% |
| Mar 4, 2026 | Perrigo to Present at the UBS Global Consumer and Retail Conference | +2.6% | +0.7% |
Earlier insider filings at PRGO
- May 15, 2026Director Parker Geoffrey M. exercised 7,305 units of Ordinary Shares at a strike of $10.84 and covered exercise/tax liability with 3,507 units of Ordinary Shares, increasing direct ownership by 13% to 32,710 units (SEC Form 4)
- May 15, 2026SEC Form 4 filed by CEO Lockwood-Taylor Patrick
- May 15, 2026SEC Form 4 filed by EVP & Chief Financial Officer Bezerra Eduardo Guarita
- May 15, 2026SEC Form 4 filed by EVP and CSO Lennox Abigail
- May 15, 2026SEC Form 4 filed by EVP and President of CSCI Khoury Roberto
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow PRGO and get a push notification the moment its next story breaks.